Updated October 12, 2005
Laboratory Specimen Acceptability QT3
A substantial amount of rework, diagnostic and therapeutic delay, and patient
inconvenience can result from specimen rejection. Patient redraws may be due
to issues including unlabeled, mislabeled, and incompletely labeled specimens;
clotted and/or hemolyzed specimens; and insufficient specimen quantity. By continuously
monitoring specimen acceptability, collection, and transport, problems can be
promptly identified and corrected, leading to improved patient care. Participation
in this monitor can help satisfy the CAP’s checklist question, “Are preanalytic
Identify and characterize unacceptable blood specimens that are submitted to the chemistry and hematology sections of the clinical laboratory for testing.
This monitor includes all blood specimens submitted for testing to the chemistry and hematology departments of the clinical laboratory. Weekly tallies on the total number of specimens received, the number of rejected specimens, and the primary reason each specimen is rejected will be recorded.
- Specimen Rejection Rate (%)
- Breakdown of Rejection Reasons (%)
Input forms for quarterly data will be sent to participants approximately three weeks prior to the quarter.